Editor's note: This article originally appeared March 17, 2020, and is being shared again this week as a "Best of 2020" article. Enjoy!
Editor's note: This article originally appeared May 18, 2020, and is being shared again as a "Best of 2020" article as we wrap up this year.
Following the FDA issuance of an Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine, the Advisory Committee on Immunization Practices (ACIP) issued interim recommendations for the prevention of COVID-19 in persons aged ≥16 years.
The exponential rise in deaths from the coronavirus (COVID-19) in the last several months is put into perspective by JAMA Viewpoint article noting that current US death rates of > 3000 per day from COVID-19 is greater than that seen in one day on September 11, 2001 (9/11 attacks, clai
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com.
Patients with rheumatic and inflammatory diseases who develop COVID-19 share risk factors for severe disease with the larger population, including older age, male sex, obesity, and hypertension, but also are at increased risk if they are on corticosteroids, French investigators reported.
I have been an investigator for many clinical rheumatology studies over the past two decades but have never been a study subject until now. I wanted to document my experience and allay any fears about the vaccine or the clinical trials process.
As we inch closer to a possible vaccine for COVID-19, we are finally filling in the details on how the pandemic is affecting every aspect of our patient’s lives.